LIDOCAINE HYDROCHLORIDE 5% AND DEXTROSE 7.5% Drug Patent Profile
✉ Email this page to a colleague
When do Lidocaine Hydrochloride 5% And Dextrose 7.5% patents expire, and when can generic versions of Lidocaine Hydrochloride 5% And Dextrose 7.5% launch?
Lidocaine Hydrochloride 5% And Dextrose 7.5% is a drug marketed by Hospira and is included in one NDA.
The generic ingredient in LIDOCAINE HYDROCHLORIDE 5% AND DEXTROSE 7.5% is lidocaine hydrochloride. There are twenty-nine drug master file entries for this compound. Fifty suppliers are listed for this compound. Additional details are available on the lidocaine hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Lidocaine Hydrochloride 5% And Dextrose 7.5%
A generic version of LIDOCAINE HYDROCHLORIDE 5% AND DEXTROSE 7.5% was approved as lidocaine hydrochloride by WOCKHARDT BIO AG on November 18th, 1982.
Summary for LIDOCAINE HYDROCHLORIDE 5% AND DEXTROSE 7.5%
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 42 |
Clinical Trials: | 1,780 |
Formulation / Manufacturing: | see details |
DailyMed Link: | LIDOCAINE HYDROCHLORIDE 5% AND DEXTROSE 7.5% at DailyMed |
Recent Clinical Trials for LIDOCAINE HYDROCHLORIDE 5% AND DEXTROSE 7.5%
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Arkansas Children's Hospital Research Institute | Phase 4 |
Indonesia Endowment Fund for Education | Phase 4 |
Universitas Sebelas Maret | Phase 4 |
See all LIDOCAINE HYDROCHLORIDE 5% AND DEXTROSE 7.5% clinical trials
Anatomical Therapeutic Chemical (ATC) Classes for LIDOCAINE HYDROCHLORIDE 5% AND DEXTROSE 7.5%
US Patents and Regulatory Information for LIDOCAINE HYDROCHLORIDE 5% AND DEXTROSE 7.5%
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Hospira | LIDOCAINE HYDROCHLORIDE 5% AND DEXTROSE 7.5% | lidocaine hydrochloride | INJECTABLE;SPINAL | 083914-001 | Approved Prior to Jan 1, 1982 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |